Can GLP-1 Agonists Represent a Meaningful Therapeutic Option for People with Obstructive Sleep Apnea (OSA)?
Time: 9:30 am
day: Conference Day One
Details:
- Discussing the clinical and economic burden of OSA
- Understanding the basic pathophysiology of the disease and why GLP-1 RAs may be a valid treatment option
- Evaluating the current treatment options for OSA and exploring the benefits GLP-1 RAs may bring
- Reflecting on challenges and future plans to expand GLP-1 therapies into this area
